The largest database of trusted experimental protocols

Thapsigargin tp

Manufactured by Merck Group

Thapsigargin (TP) is a natural product derived from the plant Thapsia garganica. It is a potent inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) enzyme, which plays a crucial role in the regulation of intracellular calcium homeostasis. TP is commonly used as a research tool in cell biology and biochemistry studies to investigate calcium signaling pathways and the function of the endoplasmic reticulum.

Automatically generated - may contain errors

2 protocols using thapsigargin tp

1

Antibodies and Reagents for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse monoclonal antibodies against GAPDH and actin, rabbit polyclonal antibodies against PTEN, PERK, phosphorylated elF2 and CHOP were from Cell Signaling Technologies. β-tubulin III antibody, thapsigargin (TP) and sodium phenylbutyrate (4-PBA) were from Sigma-Aldrich. Anti-Phosphorylated PERK antibody was obtained from Santa Cruz Biotechnology. Aβ1−42 was purchased from China Peptide. The mimic or inhibitors of miR-200 family and siPTEN/control siRNAs were synthesized by Life Technologies with sequences shown in Table 1.
+ Open protocol
+ Expand
2

Dectin-1 Pathway Modulation in mDC

Check if the same lab product or an alternative is used in the 5 most similar protocols
10μg/ml mouse IgG2B dectin-1 blocking antibody (clone-259931 R&D Systems), 10ug/ml mouse IgG2B isotype control (clone-20116 R&D Systems), 5μM Syk inhibitor, R406 (Selleckchem), 10μM NFκB inhibitor, isohelenin (Calbiochem), 1μM p38 MAPK inhibitor, BIRB0796 (Selleckchem), 5μg/ml anti-TNFα, Infliximab (JannsenBiotech), 1μg/ml IL-1 receptor antagonist (IL-1RA) (R&D Systems), 50μM caspase-1 inhibitor (Z-YVAD-FMK) (Calbiochem), 50μM caspase-8 inhibitor (Z-IE(OMe)TD(OMe)-FMK) (Calbiochem), 10ng/ml TNFα (Biolegend), 10ng/ml IL-1β (Miltenyi), 1μg/ml tunicamycin (TM) (Sigma-Aldrich), 0.25μM thapsigargin (TP) (Sigma-Aldrich), 30μM IRE1α inhibitor, 4μ8C (Calbiochem) and 1μM GSK-PERK inhibitor (Toronto Research). Where inhibitors, blocking antibodies and modifiers were used, mDC were pre-treated one hour prior to cell stimulation. Repeated experiments were performed on independent donors unless otherwise stated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!